References
- Nussenzveig RH, Burjanivova T, Salama ME, et al. Detection of JAK2 mutations in paraffin marrow biopsies by high resolution melting analysis: identification of L611S alone and in cis with V617F in polycythemia vera. Leuk Lymphoma 2012;53:2479–2486.
- Scott LM. The JAK2 exon 12 mutations: a comprehensive review. Am J Hematol 2011;86:668–676.
- Schnittger S, Bacher U, Eder C, et al. Molecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflow. Haematologica 2012;97:1582–1585.
- Kjaer L, Westman M, Hasselbalch Riley C, et al. A highly sensitive quantitative real-time PCR assay for determination of mutant JAK2 exon 12 allele burden. PLoS One 2012;7:e33100.
- Dunbar SA. Applications of Luminex xMAP technology for rapid, high-throughput multiplexed nucleic acid detection. Clin Chim Acta 2006;363:71–82.
- Shivarov V, Ivanova M, Hadjiev E, et al. Rapid quantification of JAK2 V617F allele burden using a bead-based liquid assay with locked nucleic acid-modified oligonucleotide probes. Leuk Lymphoma 2011;52:2023–2026.
- Paradis FW, Simard R, Gaudet D. Quantitative assay for the detection of the V617F variant in the Janus kinase 2 (JAK2) gene using the Luminex xMAP technology. BMC Med Genet 2010;11:54.
- Passamonti F, Elena C, Schnittger S, et al. Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations. Blood 2011;117:2813–2816.
- Ivanova MI, Shivarov VS, Hadjiev EA, et al. Novel multiplex bead-based assay with LNA-modified probes for detection of MPL exon 10 mutations. Leuk Res 2011;35:1120–1123.
- Wallace J, Zhou Y, Usmani GN, et al. BARCODE-ALL: accelerated and cost-effective genetic risk stratification in acute leukemia using spectrally addressable liquid bead microarrays. Leukemia 2003;17:1404–1410.
- Hafez M, Ye F, Jackson K, et al. Performance and clinical evaluation of a sensitive multiplex assay for the rapid detection of common NPM1 mutations. J Mol Diagn 2010;12:629–635.
- Lippert E, Girodon F, Hammond E, et al. Concordance of assays designed for the quantification of JAK2V617F: a multicenter study. Haematologica 2009;94:38–45.